Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy [Seeking Alpha]
Assessing Nuvation Bio (NUVB) Valuation After Bullish Analyst Calls On Ibtrozi And mIDH1 Glioma Potential [Yahoo! Finance]
Truist Highlights Nuvation Bio's (NUVB) Ibtrozi's Robust Market Uptake and Lead Over Competitors [Yahoo! Finance]
Nuvation Bio (NYSE:NUVB) was given a new $13.00 price target on by analysts at Truist Financial Corporation.
Nuvation Bio (NYSE:NUVB) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.